Home/Investors/British Patient Capital

British Patient Capital

Biotech Investor · 2 portfolio companies

Portfolio

2

Focus Areas

6

Top Stage

Pre-clinical

Investment Focus

Chronic Pain Autoimmunity Cardiovascular Disease Immunology Oncology Metabolic

Portfolio Companies

Company	Stage	Valuation	Focus
Maxion Therapeutics	Pre-clinical	—	Chronic Pain, Autoimmunity
The Bland Company	platform	—	Immunology, Oncology

Frequent Co-Investors

LifeArc Ventures1 shared General Catalyst1 shared SV Health Investors1 shared Monograph Capital1 shared IP Group1 shared Eli Lilly and Company1 shared British Growth Fund1 shared Solasta Ventures1 shared